PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma
Kui Wang(Peking University), Edouard C. Nice(Monash University), Guobo Shen(Sichuan University), Xingyun Wu(Sichuan University), Hai‐Ning Chen(Sichuan University), Lunzhi Dai(Sichuan University), Yong Peng(Chengdu Medical College), Shuyue Fu(Sichuan University), Zihao Wang(Anhui University), Mao Wang(Shanxi Medical University), Lixia Dong(Sichuan University), Xiawei Wei(Sichuan University), Li Luo(State Key Laboratory of Biotherapy)
Cited by 120
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
Targeting PI3K in cancer: mechanisms and advances in clinical trials
|Molecular Cancer|2019|1.6k
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
|Signal Transduction and Targeted Therapy|2019|1.1k
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
|Journal of Hematology & Oncology|2022|964